Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI

Age
18 years - 99 years
Gender
All
participants needed
15
Location
1
Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI

Brief description of study

The primary outcomes will be to establish the safety and feasibility of inhaled imaging in patients with NSCLCand to develop a robust RT planning protocol incorporating both standard of care metrics and those derived from inhaled imaging

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research,non-small cell lung carcinoma (NSCLC)
  • Age: 18 years - 99 years
  • Gender: All


Updated on 04 Aug 2024. Study ID: 849026
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research